22hon MSN
Why Merck Is Sinking This Week
The stock for pharmaceutical giant Merck (NYSE: MRK) was trading down more than 3% Monday morning. That's a big drop in just ...
Eli Lilly just struck a major deal with the world's largest retailer. GLP-1 drugs may have uses beyond obesity and diabetes ...
Medpage Today on MSN
World's Best-Selling Med; Cost-Effectiveness of GLP-1 Drugs; TED Drug Heads to FDA
An Institute for Clinical and Economic Review report concluded that the GLP-1 drugs tirzepatide and semaglutide (Ozempic, ...
The oncology adjuvants market is expanding due to rising cancer rates, personalized medicine demand, and advances in ...
The company will open two new distribution centers and expand a third as demand surges for GLP-1s and other refrigerated ...
THOUSAND OAKS, Calif., Nov. 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2025.
Phase 2b data for rosnilimab in rheumatoid arthritis featured as late-breaking oral presentation at ACR Convergence 2025 Phase 1b initiated in celiac disease for ANB033, a CD122 antagonist; top-line ...
Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...
The deal hands Blackstone a piece of the potential future sales of an antibody-drug conjugate that could soon challenge marketed medicines from AstraZeneca and Gilead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback